Clinical trial

S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With…

NCT00006487 · SWOG Cancer Research Network, Other · Completed

Key facts

NCT number NCT00006487
Title S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer
Official title A Phase I Study Of Tirapazamine/Cisplatin/Etoposide And Concurrent Thoracic Radiotherapy For Limited Stage Small Cell Lung Cancer
Lead sponsor SWOG Cancer Research Network, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Lung Cancer
Intervention type Drug, Radiation
Interventions cisplatin, etoposide, tirapazamine, radiation therapy
Enrollment 30
Start date Oct 1, 2000
Primary completion Jul 1, 2004
Completion Jul 1, 2004
First posted Apr 2, 2004
Last update posted Oct 4, 2012
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies